Finally! Note: This is Part 1 of a 3-part series of posts on the relevance of neuropsychological assessment in the context of lecanemab, a newly approved Alzheimer’s treatment. Part 1: What is lecanemab and what does it do? Health Canada recently approved lecanemab, a new treatment for Alzheimer’s disease. Lecanemab is also known by its brandname, Leqembi. This is exciting news because lecanemab is the first disease-modifying treatment approved in Canada for Alzheimer’s d

Many adults consult a healthcare professional for symptoms consistent with ADHD: Problems with attention, concentration, organization,...

Guest blog by Jie Chang Everyone experiences cognitive fatigue from time to time (if you ever procrastinated to study for a test, you...